NCI Phase III Trial On Shark Cartilage May Begin Recruitment Summer/Fall
This article was originally published in The Tan Sheet
Executive Summary
A National Cancer Institute Phase III trial on the effects of shark cartilage on stages 3a and 3b inoperable non-small cell lung cancer may begin recruitment in the late summer or early fall.
You may also be interested in...
Lane Labs FTC Settlement To Fund National Cancer Institute Study
Lane Labs has been ordered by the Federal Trade Commission to contribute $450,000 to fund a National Cancer Institute clinical study on the effects of shark cartilage supplementation on cancer as part of a $1 mil. settlement of charges it made unsubstantiated cancer claims for its dietary supplements.
Lane Labs FTC Settlement To Fund National Cancer Institute Study
Lane Labs has been ordered by the Federal Trade Commission to contribute $450,000 to fund a National Cancer Institute clinical study on the effects of shark cartilage supplementation on cancer as part of a $1 mil. settlement of charges it made unsubstantiated cancer claims for its dietary supplements.
Lane Labs FTC Settlement To Fund National Cancer Institute Study
Lane Labs has been ordered by the Federal Trade Commission to contribute $450,000 to fund a National Cancer Institute clinical study on the effects of shark cartilage supplementation on cancer as part of a $1 mil. settlement of charges it made unsubstantiated cancer claims for its dietary supplements.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: